Omeros reports Q3 2026 results, CHMP negative opinion on narsoplimab in EuropeNov 16Quarterly updatenarsoplimabOmeros Corporation
Omeros reports Q2 2026 results as YARTEMLEA sales climb and CHMP issues negative opinionAug 12Quarterly updatenarsoplimabOmeros Corporation